The ACI\'s 2nd Practical and Tactical Art of the Deal in

Medical Device Agreements: M&A, Licensing, Co-Development, and Collaborations

Creating Value Through Strategic Partnerships, IP Protection, and Business Development

Tuesday, November 19 to Wednesday, November 20, 2013
Chicago-Mart Plaza (Riverview), Chicago, IL

“By 2016, the global medical device market will approach US$350 billion, an annual average growth of 5% from 2011.”*

Product development and protection of IP is fundamental to the success and growth of any medical device company, but the road to placing a product on the market is fraught with time concerns and monetary risks. In an effort to fi ll their product pipeline, reduce development costs and leverage existing assets, virtually all medical device companies are increasingly relying on collaborations with each other, with providers, and with research institutions. Choosing and working with the right partners in the context of a well-crafted agreement can help assuage those risks and give your company and investors the best shot of a successful ROI.

Find out what a panoply of licensing professionals from leading industry players are doing to keep pushing innovation to market through regulatory uncertainty, legal shifts, and an ever-changing economic climate.

Based on extensive research with industry experts, ACI is proud to present its 2nd Annual Medical Device Agreements: M&A, Licensing, Co-Development, and Collaborations as an advanced strategic meeting bringing together industry leaders to analyze the practical impact of FDA regulations, payment structures, IP considerations, and developmental hurdles on deal making strategies. The seasoned faculty — including representatives from Boston Scientific, Medtronic, 3M, Cook Medical, Stryker, Covidien and more — will discuss and share insights on the most pressing issues facing deal makers including:

• How industry insiders are developing their product pipeline

• What diligence is essential to evaluate prospective deals and potential partners

• Strategies on how to effectively approach and negotiate with key innovation contributors including academics and physicians

• What kinds of medical device deals are being made, and how do your partnerships compare

• How to craft agreement documents with an eye to moving a deal forward and maintaining the relationship while protecting your organization’s investment and future role in the process

Do not miss this opportunity to join your medical device licensing colleagues in an advanced think-tank discussion regarding how to maximize the economic advantages and risk management of partnerships. As this event is sure to sell out, reserve your place today to ensure you are a part of the discussion by calling 888-224-2480, faxing your registration form to 877-927-1563 or registering on-line at

* The Outlook for Medical Devices Worldwide, Espicom Business Intelligence, May 2012

Enhance and complete your conference experience by attending one or both of the workshops:

Monday, November 18, 2013

In-Depth Preconference Workshop on the Device Approval Pathway: Evaluating and Overcoming Risks in Partnership Agreements
In this interactive primer, the expert speakers will provide you with a clear overview of the FDA regulations which will lay the foundation for the strategic discussions to come in the main conference.  Discussion will include tips on how to gracefully negotiate with the FDA to advance your position.

Thursday, November 21, 2013

Post-Conference Master Class: Global Deal Making - Opening Doors to New Markets and Products with Strategic Alliances
Gain cutting edge insight into how to manage export controls, avoid common pitfalls associated with international agreements, and evaluate potential partners.